Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 6/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | PYGB | P11216 | 3/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173142 | 1.00 | PRKCA (0.39) | PRKCAMAPK1PYGBPYGL | |
| SCHEMBL1173385 | 0.93 | FAAH (0.40) | — | |
| SCHEMBL9095367 | 0.88 | PYGB (0.40) | PRKCAMAPK1PYGBPYGL | |
| SCHEMBL4322129 | 0.82 | CDK1 (0.36) | PRKCAMAPK1PYGB | |
| SCHEMBL17781741 | 0.79 | PYGB (0.43) | MAPK1PYGBPYGL | |
| SCHEMBL8067513 | 0.79 | PRKCA (0.42) | PRKCAMAPK1PYGBPYGL | |
| SCHEMBL29201539 | 0.79 | PYGB (0.36) | PRKCAMAPK1PYGB | |
| SCHEMBL28999763 | 0.79 | PYGB (0.36) | PRKCAMAPK1PYGB | |
| SCHEMBL1665805 | 0.78 | MAPK1 (0.44) | PRKCAMAPK1PYGB | |
| SCHEMBL2122988 | 0.78 | MAPK1 (0.44) | PRKCAMAPK1PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240180798-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-06 | — | — | US | claimed |
| US-20240173220-A1 | Oral Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2024-05-30 | — | — | US | claimed |
| WO-2024112780-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-05-30 | — | — | WO | claimed |
| WO-2024112627-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-05-30 | — | — | WO | claimed |
| US-10555893-B2 | Leave-on hair styling compositions and methods of use | L'OREAL (FR) | 2020-02-11 | — | — | US | claimed |
| US-20180243204-A1 | LEAVE-ON HAIR STYLING COMPOSITIONS AND METHODS OF USE | L'OREAL (FR) | 2018-08-30 | — | — | US | claimed |
| US-8858922-B2 | Broad spectrum UVA stable, non-toxic, zinc oxide based complex | 3rd Rock Sunblock, Inc. (US) | 2014-10-14 | — | — | US | claimed |
| US-8465729-B2 | Sunscreen compositions with SPF enhancer | PLAYTEX PRODUCTS, INC. (US) | 2013-06-18 | — | — | US | claimed |
| US-20120263661-A1 | Broad Spectrum UVA Stable, Non-Toxic, Zinc Oxide Based Complex | GRUNE GUERRY L (US) | 2012-10-18 | — | — | US | claimed |
| EP-2501777-A2 | BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX | Grune, Guerry L. (US) | 2012-09-26 | — | — | EP | claimed |
| WO-2011063329-A2 | BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX | GRUNE GUERRY L (US) | 2011-05-26 | — | — | WO | claimed |
| US-6830746-B2 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2004-12-14 | — | — | US | claimed |
| WO-2003026595-A1 | SUNSCREEN COMPOSITIONS | PLAYTEX PRODUCTS, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-20030059383-A1 | Sunscreen compositions | PLAYTEX PRODUCTS, INC. | 2003-03-27 | — | — | US | claimed |
| WO-2024137603-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024137556-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024137453-A1 | ORAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20020055562-A1 | Gel compositions | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2002-05-09 | — | — | US | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240180798-A1 | Oral Care Compositions | SPTAN1, SPTBN1, ASS1 | PRKCA 2111/4885MAPK1 3942/4885PYGB 3990/4885 |
| US-20240173220-A1 | Oral Care Compositions | S100A9, PHOSPHO1, AP3S1 | PRKCA 1627/4885MAPK1 3931/4885PYGB 3497/4885 |
| US-20180243204-A1 | LEAVE-ON HAIR STYLING COMPOSITIONS AND METHODS OF USE | SUCLG1, DPM1, WAPL | PRKCA 4191/4885MAPK1 3972/4885PYGB 757/4885 |
| US-10555893-B2 | Leave-on hair styling compositions and methods of use | SUCLG1, DPM1, WAPL | PRKCA 4191/4885MAPK1 3972/4885PYGB 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.